Dow Up0.51% Nasdaq Up0.24%

More On NNLX



News & Info


Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates


  • Major Holders
  • Insider Transactions
  • Insider Roster


  • Income Statement
  • Balance Sheet
  • Cash Flow

NanoLogix Inc. (NNLX)

-Other OTC
0.06 Down 0.01(12.15%) Nov 21, 3:51PM EST
ProfileGet Profile for:
NanoLogix Inc.
843 North Main Street
Hubbard, OH 44425
United States - Map
Phone: 330-534-0800
Fax: 330-534-0826

Index Membership:N/A
Full Time Employees:N/A

Business Summary 

NanoLogix, Inc., a biotechnology company, produces and delivers test kits for use in the rapid detection of live cell microorganisms present in infectious and noninfectious human diseases, the environment, industrial settings, veterinary medicine, and research and testing laboratories. It offers BioNanoPore Petri-based sandwiched-membrane kits that detect active threat bacteria and other microorganisms; BioNanoFilter to detect and identify live-cell microorganisms in small and large-volume samples; and Tryptic Soy Agar (TSA) plates that consist of a general purpose media, which is used for the isolation and cultivation of various fastidious and nonfastidious microorganisms. The company’s TSA plates also display growth of aerobic and anaerobic microorganisms. Its products have applications in medical, national defense, and homeland security; and pharmaceutical, industrial, veterinary, and environmental testing. The company’s products have applicable in the areas of applied microbiology, soil microbiology, medical diagnostics, microbial physiology, molecular biology, pharmacology, pharmaco-kinetics, antibiotic sensitivity, stem-cell research, and hydrogen generation through use of bioreactors. It sells to medical and scientific entities, including laboratories, medical institutions, universities, businesses, and research establishments; and online. The company is based in Hubbard, Ohio.

Key Statistics

Company Websites 
Home Page
Search Yahoo! for:
More on NanoLogix Inc.

Key Executives 
Mr. Bret T. Barnhizer , 63
Chairman, Chief Exec. Officer and Pres
Ms. Carol J. Surrena ,
Corp. Sec.
Mr. Daniel D. Barnhizer ,
Gen. Counsel and Director
Mr. William Lewis ,
VP of Sales and Marketing
Ms. Michelle Durkin ,
Director of Laboratory Operations & New Product Devel. and Member of Scientific Advisory Board
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.